Bondi Sands Broad Spectrum Hydra UV Protect SPF 70 Face Fluid

Bondi Sands Broad Spectrum Hydra UV Protect SPF 70 Face Fluid by

Drug Labeling and Warnings

Bondi Sands Broad Spectrum Hydra UV Protect SPF 70 Face Fluid by is a Otc medication manufactured, distributed, or labeled by Baxter Laboratories Pty. Ltd.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

BONDI SANDS BROAD SPECTRUM HYDRA UV PROTECT SPF 70 FACE FLUID- avobenzone, homosalate, octisalate, octocrylene lotion 
Baxter Laboratories Pty. Ltd.

----------

Bondi Sands Broad Spectrum Hydra UV Protect SPF 70 Face Fluid

Active Ingredients

Avobenzone 3%, Homosalate 12%, Octisalate 5%, Octocrylene 10%

Purpose

Sunscreen

Uses

  • Helps prevent sunburn
  • If used as directed with other sun protection measures ( see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.

Warnings

For external use only

Do not use on damaged or broken skin.

Stop use and ask a doctor if rash occurs.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

When using this product

keep out of eyes. Rinse with water to remove.

Directions

  • Apply liberally 15 minutes before sun exposure. Use a water resistant sunscreen if swimming or sweating.
  • Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
  • Limit time in the sun, especially from 10 a.m.- 2 p.m.
  • Wear long-sleeved shirts, pants, hats, and sunglasses.
  • Children under 6 months: Ask a doctor.

Other information

  • Protect the product in this container from excessive heat and direct sun.
  • You may report a serious adverse reaction to 888-266-0772; Monday – Friday, 9 am – 5 pm.

Inactive Ingredients

Water, Beeswax, C12-15 Alkyl Benzoate, Silica, PEG-15 Cocamine, Caprylyl Glycol, PEG-40 Stearate, Acrylates/Steareth-20 Methacrylate Copolymer, Caprylhydroxamic Acid, Glycerin, Carbomer, Aminomethyl Propanol, Phenoxyethanol, Sodium Carrageenan, Aloe Barbadensis Leaf Juice, Tocopheryl Acetate, Sodium Chloride.

Questions?

888-266-0772 or visit bondisands.com

Product Packaging

bondi sands

The Australian tan

BROAD SPECTRUM

HYDRA

UV PROTECT

SPF 70

FACE FLUID

ULTRA LIGHTWEIGHT SUNSCREEN

PLANT BASED HYDRATION

DERMATOLOGICALLY TESTED

Australian Made

1.35 FL. OZ. (40 mL)

hydra fluid

BONDI SANDS BROAD SPECTRUM HYDRA UV PROTECT SPF 70 FACE FLUID 
avobenzone, homosalate, octisalate, octocrylene lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 70157-019
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE30 mg  in 1 mL
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE100 mg  in 1 mL
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE120 mg  in 1 mL
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE50 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
CAPRYLHYDROXAMIC ACID (UNII: UPY805K99W)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
ALKYL (C12-15) BENZOATE (UNII: A9EJ3J61HQ)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
WATER (UNII: 059QF0KO0R)  
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
PEG-15 COCAMINE (UNII: 8L6LB12TSJ)  
CARRAGEENAN (UNII: 5C69YCD2YJ)  
YELLOW WAX (UNII: 2ZA36H0S2V)  
AMINOMETHYLPROPANOL (UNII: LU49E6626Q)  
GLYCERIN (UNII: PDC6A3C0OX)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
ETHYL ACRYLATE/METHACRYLIC ACID/STEARETH-20 METHACRYLATE COPOLYMER (UNII: EPA1872R1N)  
PEG-40 STEARATE (UNII: ECU18C66Q7)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 70157-019-011 in 1 CARTON08/10/202108/10/2021
140 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02008/10/202108/10/2021
Labeler - Baxter Laboratories Pty. Ltd. (740537709)

Revised: 3/2026
Document Id: 4c7560de-b1cd-cd60-e063-6294a90afe8d
Set id: 0fe14df5-1e42-6230-e063-6294a90aef05
Version: 2
Effective Time: 20260307